Abstract:Purpose Danon Disease (DD) is a rare genetic disorder that affects the cardiac, neurologic, and muscular systems in both men and women. Subjects affected typically develop hypertrophic cardiomyopathy (HCM) and end-stage heart failure requiring transplantation. DD is an X-linked disorder with women typically suffering milder disease presentations that develop later in life. Methods A global retrospective registry for DD was created to understand the disease's natural history. Data including the description of clinical features and age of symptom onset was collected from patients across the world (United States, United Kingdom, and Australia). Information was obtained via medical records and questionnaires that were collected from patients and/or their family. Results The registry includes a total of 33 patients with 54.5% being female. The major demographics of patients were Caucasian (96.9%) and from the United States (78.8%). Impartial of the affected organs, males experienced earlier symptoms compared to females (5.5 (2.0-12.0) vs 16.0 (11.5-27.0) years of age, p = 0.002) which resulted in an earlier DD diagnosis in males at (8.0 (4.0-12.0) vs 26.5 (13.0-41.0) years of age, p = 0.023). The frequency of HCM was higher in males as compared to females, (93.3% vs 44.4%) while females had a higher frequency of tachyarrhythmias compared to males (61.1% vs 13.3%). Dilated cardiomyopathy (DCM) was absent in males, however was the first symptom of cardiac disease in two female patients (11.1%). Four males (26.7%) and seven females (38.8%) underwent heart transplantation. Death occurred in one (5.6%) female due to post-transplant complications. Neurological symptoms, primarily manifesting as cognitive impairment were documented in 86.7% of males and 61.1% of females and had a similar age of onset (5.0 (4.0-10.0) vs 8.0 (7.0-15.0) years of age, p = 1). 87.9% of subjects presented with symptomatic skeletal myopathy which was more frequent in males (86.7% vs 64.3%). Conclusion Although DD is an X-linked disorder, significant cardiac morbidity develops in women. Females have a higher prevalence of DCM, which may be secondary to delayed symptom presentation and diagnosis. While DD is a rare diagnosis, healthcare providers should be aware that later clinical manifestations occur in women and should be considered in the differential diagnosis of heart failure. Danon Disease (DD) is a rare genetic disorder that affects the cardiac, neurologic, and muscular systems in both men and women. Subjects affected typically develop hypertrophic cardiomyopathy (HCM) and end-stage heart failure requiring transplantation. DD is an X-linked disorder with women typically suffering milder disease presentations that develop later in life. A global retrospective registry for DD was created to understand the disease's natural history. Data including the description of clinical features and age of symptom onset was collected from patients across the world (United States, United Kingdom, and Australia). Information was obtained via medical records and questionnaires that were collected from patients and/or their family. The registry includes a total of 33 patients with 54.5% being female. The major demographics of patients were Caucasian (96.9%) and from the United States (78.8%). Impartial of the affected organs, males experienced earlier symptoms compared to females (5.5 (2.0-12.0) vs 16.0 (11.5-27.0) years of age, p = 0.002) which resulted in an earlier DD diagnosis in males at (8.0 (4.0-12.0) vs 26.5 (13.0-41.0) years of age, p = 0.023). The frequency of HCM was higher in males as compared to females, (93.3% vs 44.4%) while females had a higher frequency of tachyarrhythmias compared to males (61.1% vs 13.3%). Dilated cardiomyopathy (DCM) was absent in males, however was the first symptom of cardiac disease in two female patients (11.1%). Four males (26.7%) and seven females (38.8%) underwent heart transplantation. Death occurred in one (5.6%) female due to post-transplant complications. Neurological symptoms, primarily manifesting as cognitive impairment were documented in 86.7% of males and 61.1% of females and had a similar age of onset (5.0 (4.0-10.0) vs 8.0 (7.0-15.0) years of age, p = 1). 87.9% of subjects presented with symptomatic skeletal myopathy which was more frequent in males (86.7% vs 64.3%). Although DD is an X-linked disorder, significant cardiac morbidity develops in women. Females have a higher prevalence of DCM, which may be secondary to delayed symptom presentation and diagnosis. While DD is a rare diagnosis, healthcare providers should be aware that later clinical manifestations occur in women and should be considered in the differential diagnosis of heart failure.

An International Longitudinal Natural History Study of Danon Disease Patients: Unique Cardiac Trajectories Identified Based on Sex and Heart Failure Outcomes

Clinical Features and Outcomes for Danon Disease: Data from Global Registry

Left Ventricular Strain and Progression of Hypertrophy in Danon Disease Cardiomyopathy: Insights from a Global Registry.

Cardiovascular magnetic resonance findings in Danon disease: a case series of a family

Clinical and genetic profile of Chinese children with Danon disease: A single-center retrospective cohort study

Cardiac Phenotype Characterization at MRI in Patients with Danon Disease: A Retrospective Multicenter Case Series

Progression of Danon Disease with Medical Imaging: Two Case Reports

Danon disease: a case report and literature review

Prevalence and clinical characteristics of Danon disease among patients with left ventricular hypertrophy and concomitant electrocardiographic preexcitation.

A Frequent Observation of Wolff-Parkinson-White Syndrome and Fasciculoventricular Pathways in Patients with Danon Disease

Case Report: Multiple Types of Arrhythmias in a Late-Confirmed Danon Disease

Identification of LAMP2 Mutations in Early-Onset Danon Disease with Hypertrophic Cardiomyopathy by Targeted Next-Generation Sequencing.

Four-dimensional Echocardiography and Left Ventricular Systolic Strain Measured Via Two-Dimensional Speckle-Tracking for Danon Disease: a Case Series.

A case report of delayed diagnosis of danon disease Caused by a newly recognized mutation in the lysosome-associated membrane protein-2 gene

Danon Disease: Two Patients with Atrial Fibrillation in a Single Family and Review of the Literature.

Identification and functional analysis of a novel de novo missense mutation located in the initiation codon of LAMP2 associated with early onset female Danon disease

A Novel LAMP2 P.g93r Mutation Associated with Mild Danon Disease Presenting with Familial Hypertrophic Cardiomyopathy.

Environmental Risk Factors Influence the Natural History of Familial Dilated Cardiomyopathy

DMD-Associated Dilated Cardiomyopathy: Genotypes, Phenotypes, and Phenocopies

Natural History, Phenotype Spectrum and Clinical Outcomes of Desmin (DES)-Associated Cardiomyopathy

Data from electronic healthcare records expand our understanding of X‐linked genetic diseases